Aircraft crew face increased risk of developing skin cancer
Frequent flyers, including pilots and flight attendants, are exposed to higher levels of ultraviolet and cosmic ionizing radiation than the general population, leading to higher rates of skin cancer.
Periorbital rejuvenation: comprehensive evaluation and product selection are key to results
With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eyes and achieve the natural-looking results patients desire.
Surveys: Do you regularly ask your patients questions about their skin care habits and routines?
This Skin Care Awareness Month, we’d like to hear more about your experiences discussing skin care habits with patients. Click to take this week’s survey.
One in four people with HS has a comorbid psychiatric disorder
Affective, anxiety, and neurotic disorders were the most common in recent studies.
ResVita Bio receives NIAID grant for atopic dermatitis research
The Small Business Innovation Research Grant enabled ResVita Bio to develop RVB-101 for the treatment of severe atopic dermatitis.
Nemolizumab improves clinical severity of prurigo nodularis
The study found that 193 proteins were differentially expressed after nemolizumab treatment.
Addressing the cultural disconnect for people with vitiligo
By providing culturally competent care, clinicians can alleviate patients’ concerns about identity and better understand the emotional burden of their symptoms.
treats all skin tones
Dr. Mona Shahriari introduces a special section in the September issue of Dermatology Times, “Psoriasis Gaps in Care,” dedicated to skin color research in psoriasis.
Roflumilast cream meets primary endpoint for treatment of atopic dermatitis
Roflumilast cream .05% for mild to moderate atopic dermatitis in children also met its secondary endpoint.
Dupilumab steadily reduces IgE levels in patients with atopic dermatitis
The researchers found that patients’ IgE levels steadily decreased regardless of the interval between doses of dupilumab.
Dermoscopy helps diagnose plaque psoriasis and nail psoriasis
Certain dermoscopy features help diagnose and determine the severity of the disease.
Antimicrobial peptides show promise in the management of atopic dermatitis
Natural and synthetic antimicrobial peptides penetrate deeper layers of the skin.
Portela Tips: What you need to know about Ozempic
This week on Pointers With Portela, 208SkinDoc discusses 5 important points about Ozempic, including side effects and hidden risks.
Accurately recognize and diagnose psoriasis in patients with colored skin
Diagnosis and treatment of psoriasis may be delayed in patients with darker skin tones, as clinical changes and erythema are less noticeable.
Frontline Forum Part 3: Improving Basal Cell Carcinoma Management
In part 3 of this Frontline Forum series, Brent Moody, MD. Sarah Aaron, MD. Justin Cohen, DO; Emily Lewis, MD, MPH. and Todd Schlesinger, MD, discuss nonsurgical treatment options for BCC management, dose titration for systemic treatment, combinations of hedgehog pathway inhibitors and immunotherapy, and more.
Overcoming topical steroid withdrawal and extreme side effects to corticosteroids
Dr. Peter Rio provides his perspective on topical steroid withdrawal, also known as skin flare syndrome or topical steroid toxicity.
Journal Digest: September 20th
This week’s collection of the latest dermatology research covers dermatological care for patients with sexual differentiation disorders, stem cell transplantation for vitiligo, switching biologic therapies for psoriasis, and combination therapy for hidradenitis suppurativa.
Considerations for preventing and managing alopecia in patients who wear religious headgear
Previous studies have demonstrated a link between religious headwear and traction alopecia.
FDA delays approval of UCB’s bimekizumab
FDA action is no longer expected in the third quarter of 2023.
Hyaluronic acid-based fillers effective in treating signs of aging
Multiple microinjections significantly improved signs of aging up to 12 weeks after the first injection.
Hidradenitis suppurativa can cause skin changes and peripheral neuropathy
Changes in the skin and nerve endings caused by HS can contribute to peripheral neuropathy.
Dermatology Times Editorial Advisory Board Session Preview: Science of Skincare Summit 2023
Here are some of the many sessions to be held at the 2023 Science of Skincare Summit in Austin, Texas. Dermatology Times® Editorial Advisory Board members are prepared to share their knowledge and insights.
Acne vulgaris patients showed no significant differences in resistance to seven antibiotics
Some resistance to azithromycin, clindamycin, and erythromycin was observed but was not statistically significant.
The Dermatologist’s Role in Healthcare and Legislative Advocacy ft. Marty Makary, MD, MPH, FACS
Public health/public policy researcher and New York Times bestselling author Marty McCurry, MD, MPH, FACS, discusses the role of physician-led legislative advocacy in health care and dermatology.
Study shows adult female patients are more likely to visit a dermatologist for acne
Researchers at Yale University School of Medicine found that tetracycline antibiotics were the most commonly prescribed acne treatments for adult female patients from 2002 to 2016.
Seek Insight: We’re looking for tough stories, unanswered questions, and more for AD Awareness Month
Share your insights ahead of National Eczema Awareness Month in October by emailing our team at DTEditor@mmhgroup.com.
Microwave therapy successfully used to treat warts in children
Complete removal of refractory warts was achieved in 68.6% of patients.
Addressing misconceptions and concerns about biosimilar use
Studies have shown that biosimilars are very similar to the originator product in terms of safety and efficacy.
Native American and Indigenous communities face dermatological barriers to care, disparities, and more
Today is National Native American Day. Dermatology Times explores the unique dermatological concerns and disparities faced by Indigenous peoples and members of Indigenous communities.
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
In the final installment of this Frontline Forum series, Brent Moody, MD. Sarah Aaron, MD. Justin Cohen, DO; Emily Lewis, MD, MPH. Todd Schlesinger, MD, reviews four real-world clinical cases of BCC and their treatments.
Combination therapy in HS requires further investigation
A systematic review found that there is generally evidence supporting the efficacy of combination therapy in hidradenitis suppurativa.
Colloidal oatmeal is effective in improving atopic dermatitis in black children
The efficacy of 1% colloidal oatmeal cream was similar to prescription barrier cream in treating mild to moderate atopic dermatitis.
CeraVe partners with George Washington University to expand residency training program
Qualified candidates must apply by October 15, 2023, with one candidate matching in March 2024.
https://www.dermatologytimes.com/view/the-weekly-roundup-september-18-22
